tiprankstipranks
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT

Sarepta Therapeutics (SRPT) Ownership - Who Owns Sarepta Therapeutics?

2,793 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 11, 2024Sold$1848795
Mar 11, 2024Sold$93550
Mar 06, 2024
Stephen Mayo
Director
Sold$385480
Mar 05, 2024Sold$200019

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024Bought$1698325
Mar 31, 2024Sold$2544594
Mar 31, 2024Bought$43574113
Mar 31, 2024Sold$116687339

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,088,801Institution8.56%1,073,707,445
7,695,475Institution8.14%1,021,497,352
3,291,648Institution3.48%436,933,356
3,181,688Insider3.37%422,337,265
2,453,500Institution2.60%325,677,590
2,324,802Institution2.46%308,594,217
2,283,656Institution2.42%303,132,497
2,071,465Institution2.19%274,966,264
1,580,418Institution1.67%209,784,685
1,540,079Institution1.63%204,430,086

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,695,475Institution8.14%1,021,497,352
3,291,648Institution3.48%436,933,356
2,283,656Institution2.42%303,132,497
2,071,465Institution2.19%274,966,264
1,580,418Institution1.67%209,784,685
1,540,079Institution1.63%204,430,086
999,416Institution1.06%132,662,480
940,900Institution1.00%124,895,066
897,900Institution0.95%119,187,246
776,314Institution0.82%103,047,920

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,802,442Institution2.96%354,957,304
2,262,089Institution2.39%286,516,193
1,399,601Institution1.48%177,273,463
1,275,685Institution1.35%161,578,262
628,629Institution0.67%83,444,213
590,465Institution0.62%78,378,324
389,941Institution0.41%51,760,768
304,237Institution0.32%40,384,419
271,220Institution0.29%36,001,743
254,018Institution0.27%33,718,349

FAQ

Who Owns Sarepta Therapeutics (SRPT)?
Currently, no data Available
What percentage of Sarepta Therapeutics (SRPT) stock is held by institutional investors?
Currently, no data Available
What percentage of Sarepta Therapeutics (SRPT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Sarepta Therapeutics (SRPT)?
Vanguard owns the most shares of Sarepta Therapeutics (SRPT).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis